Dyslipidemia of Obesity Intervention in Teens

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

Also called NCT02956590

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 122 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02956590
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02956590. Randomized; quadruple masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2023-04-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dyslipidemia of Obesity Intervention in Teens
Acronym
DO IT!
Condition
Dyslipidemia
Condition
Obesity
Intervention (Drug)
Pitavastatin
Intervention (Drug)
Placebo
Lead sponsor
Carelon Research (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02956590
Content hash
acb2457eb8a6d14e3fdbf0504f47182c30901095b162c2c6fc17ef9ecec744d6